Longitudinal Morphometric Changes Following SCI
1 other identifier
observational
94
1 country
1
Brief Summary
In patients with chronic spinal cord injury, imaging of the spinal cord and brain above the level of the lesion provides evidence of neural degeneration; however, the spatial and temporal patterns of progression and their relation to clinical outcomes are uncertain. New interventions targeting acute spinal cord injury have entered clinical trials but neuroimaging outcomes as responsive markers of treatment have yet to be established. We aim to use MRI to assess neuronal degeneration above and below the level of the lesion after acute spinal cord injury. In our prospective longitudinal study, we enroll patients with acute traumatic spinal cord injury and healthy controls. We assess patients clinically and by MRI at baseline, 2 months, 6 months, 12 months, and if possible 24 months and 60 months follow-up, and controls by MRI at the same timepoints. We assess cervical atrophy in white and gray matter and use cross-sectional spinal cord area measurements to assess atrophy at cervical level (C2/C3) and in the lumbar enlargement. We use myelinsensitive magnetisation transfer (MT) and longitudinal relaxation rate (R1) maps in the brain to assess microstructural changes associated with myelin. We also use diffusion tensor imaging acquired in the spinal cord at C2/C3 and in the lumbar enlargement to identify axonal loss and demyelination in the spinal white matter. Finally, we assess associations between MRI parameters and clinical improvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 16, 2014
CompletedFirst Posted
Study publicly available on registry
May 29, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedSeptember 17, 2020
August 1, 2020
9 years
May 16, 2014
September 15, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Cord and brain volume (mm^3) changes
Patients will be recruited within the first months of injury and scanned 6 times during the first 5 years post injury. Healthy controls will follow the same time line.
Study Arms (2)
SCI subjects
healthy control subjects
Eligibility Criteria
Acute and chronic patients with spinal cord involvement
You may qualify if:
- SCI patients:
- acute injury to the spinal cord
- no medical or mental illness
- written informed consent
- over the age of 18 years
- Control subjects:
- over the age of 18 years
- written informed consent
You may not qualify if:
- SCI patients:
- head or brain lesion associated with the trauma leading to the injury
- epileptic seizures
- MRI contraindications
- pregnant women or lactating women
- Control subjects:
- pregnant women or lactating women
- MRI contraindications
- neurological or psychiatric illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Zurichlead
- Foundation Wings For Lifecollaborator
Study Sites (1)
University of Zurich
Zurich, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 16, 2014
First Posted
May 29, 2014
Study Start
September 1, 2010
Primary Completion
September 1, 2019
Study Completion
September 1, 2019
Last Updated
September 17, 2020
Record last verified: 2020-08